Regulatory & Policy Updates

SHERIDAN, WYOMING - April 03, 2026 - Wholesale energy market participants operating across EU borders now face a materially different compliance environment: ACER's newly published Rules of Procedure for cross-border investigations establish the procedural framework under which the agency exercises its expanded investigatory mandate, granted by EU legislators in 2024 under the revised REMIT framework. The 43rd edition of the REMIT Quarterly sets out these rules in full and signals an accelerating enforcement posture across European energy markets.

SHERIDAN, WYOMING - March 31, 2026 - Climate resilience planning is moving into 2026 healthcare procurement, regulatory, and supply-chain decisions as the European Commission develops an Integrated Climate Resilience Framework that could shape how medical technology manufacturers invest, document compliance, and maintain uninterrupted access to devices and diagnostics. In February 2026, MedTech Europe responded to the Commission's public consultation and argued for a holistic healthcare system response built on smart investments, better coordination, consistent policy frameworks, and improved collaboration across healthcare actors.

SHERIDAN, WYOMING - March 31, 2026 - Gas shippers and large energy users in Slovakia face a tougher tariff-planning environment in 2026 because ACER has found that key elements of the country's proposed gas transmission pricing framework cannot yet be confirmed as aligned with EU tariff rules, creating potential changes to cost recovery, cross-border trade conditions, and final regulatory decisions. ACER's report reviews the reference price methodology proposed by Eustream, Slovakia's transmission system operator, for the 2026-2027 multi-year tariff period and sets out where the Slovak regulator ÚRSO should tighten the approach before adoption.

SHERIDAN, WYOMING - March 31, 2026 - Early-stage medtech companies could regain a key non-dilutive funding route in 2026 after the Senate passed legislation to reauthorize the federal Small Business Innovation Research and Small Business Technology Transfer programs, reducing uncertainty that has persisted since the programs' authorization lapsed on September 30, 2025. AdvaMed said the Senate action restores momentum for grants that support early research and development at startups and small manufacturers, and it urged the House of Representatives to move quickly on passage. The association framed the programs as an important bridge for companies that struggle to finance next-generation device development before products reach patients or later-stage commercial milestones.

SHERIDAN, WYOMING - March 23, 2026 - Energy traders, compliance teams and market surveillance leaders in Europe face a more direct enforcement environment in 2026 as ACER sets the procedural framework for cross-border REMIT investigations and advances new reporting guidance under the revised regime. The 43rd edition of ACER's REMIT Quarterly centers on new Rules of Procedure for cross-border investigations, a practical step after EU legislators updated the REMIT framework in 2024 and gave ACER additional tasks, including the power to investigate cross-border cases. The quarterly also outlines ACER's stakeholder engagement plan for 2026, ongoing preparatory work on data reporting pending finalisation of the revised REMIT Implementing Regulation, and market surveillance updates tied to wholesale energy market integrity across the EU.

SHERIDAN, WYOMING - March 23, 2026 - Renewable electricity sourcing decisions in 2026 face closer regulatory scrutiny as ACER begins a public consultation that will shape its annual assessment of the EU power purchase agreements market and highlight where national rules still slow adoption. The consultation opened on 31 March 2026 and runs until 8 May 2026, focusing on developments, existing initiatives and the challenges faced by market participants across EU Member States. ACER is using the process to identify the regulatory, market and financial factors affecting how PPAs develop and function across the bloc.

SHERIDAN, WYOMING - March 23, 2026 - Medical device procurement, market-entry, and sourcing decisions for 2026 shift as the EU-India Free Trade Agreement moves from negotiation to implementation, reducing tariff friction on most EU-made devices entering India and putting more weight on customs, conformity assessment, and regulatory execution. The agreement carries direct implications for patient access, market access, and competitiveness in the medical technology sector. For EU manufacturers and Indian buyers, the practical change is that a major cost barrier on cross-border device trade is set to ease while compliance and trade processes become a more important part of operational planning.

SHERIDAN, WYOMING - March 23, 2026 - Danish gas tariff decisions in 2026 face a more demanding transparency test, with direct implications for how shippers, storage users and regulators evaluate network charges tied to upstream infrastructure. ACER's latest report reviews Energinet's proposed reference price methodology under the EU Network Code on Harmonised Transmission Tariff Structures and finds that while several core design elements align with the rules, the cost treatment of the upstream Baltic Pipe section cannot yet be fully assessed because key detail is missing.

SHERIDAN, WYOMING - March 09, 2026 - MedTech Europe participated in the first in‑person meeting of the HERA Industrial Cooperation Forum on 6 February 2026, a session in which the European Commission presented HERA's annual workplan and launched two technical working groups. The association used the meeting to underline the operational importance of medical technologies in health responses and to press for practical industry involvement in preparedness exercises. MedTech Europe also flagged the potential burden from additional reporting requirements and said forthcoming work will focus on supply‑chain risks and on supporting development, manufacturing, availability and accessibility of medical countermeasures.